宏利公積金推疫苗接種大抽獎 頭獎85萬元紅利單位回贈
宏利公積金宣佈推出新冠疫苗接種大抽獎,送出總值超過850萬港元紅利單位回贈予宏利強積金新舊客戶。
大抽獎三重賞分別覆蓋持有適用宏利強積金帳戶的現有成員、於指定時間供款至宏利個人帳戶/可扣稅自願性供款帳戶的新舊成員;以及於指定時間每月作出指定供款至可扣稅自願性供款的宏利強積金新舊成員。
只要相關成員於今年8月底前接種最少一劑冠狀病毒病疫苗、並在10月底前完成接種第二劑,便可於8月16日至9月30日或之前透過網上登記參與抽獎。三輪大抽獎每次均設有85個獎項,頭獎紅利單位回贈價值高達85萬港元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.